Biotech Values

[DewDiligence]

TBIO reverse merges into Precipio Diagnostics, LLC:

http://finance.yahoo.com/news/transgenomic-precipio-diagnostics-announce-planned-023000904.html

…the original Precipio security holders will receive between 62% and 80% of the outstanding shares of the combined company, depending on the relative amount of outstanding liabilities of the parties at closing and prior to the investment of new capital.

…Precipio Diagnostics has built a platform to harness the intellect, expertise and technology developed within academia, delivering quality diagnostic information to physicians and patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, and its experience delivering quality service, Precipio Diagnostics offers a new standard of diagnostic accuracy enabling the highest level of patient care.

LOL re Precipio mission statement.